2024-2028年全球糖尿病管理设备市场

概述

2023-2028年，糖尿病管理设备市场估计价值为139.8亿美元，预测期内复合年增长率为7.68%。

该报告包括对糖尿病管理设备市场的总体分析、市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。

它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。全球糖尿病负担日益增加、对先进胰岛素输送设备的需求不断增长以及新产品的推出推动了市场的发展。

研究指出，对人工胰臟的日益关注是推动未来几年糖尿病管理设备市场成长的关键因素之一。此外，人们对居家医疗的日益关注以及医疗保健领域的技术进步导致了市场的巨大需求。

目录

第一章执行摘要

• 市场概况

第二章 市场形势

• 市场生态系统

第三章 市场规模

• 市场定义
• 细分市场分析
• 2023 年市场规模
• 2023-2028年市场展望

第四章 市场规模表现

• 2018-2022年全球糖尿病管理设备市场
• 2018-2022年产品細項分析
• 2018-2022年通路細項分析
• 2018-2022 年区域細項分析
• 2018-2022 年国家細項分析

第五章五力分析

• 五力摘要
• 买方议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第六章市场区隔：依产品

• 细分市场
• 比较：按产品
• 血糖测量设备：2023-2028年市场规模及预测
• 胰岛素输送系统：2023-2028 年市场规模与预测
• 市场机会：依产品分类

第七章市场区隔：按分销管道

• 细分市场
• 比较：按分销管道
• 线下：2023-2028年市场规模及预测
• 线上：2023-2028 年市场规模与预测
• 市场机会：依分销管道划分

第八章 客户形势

• 客户形势概览

第九章 地区形势

• 区域细分
• 区域比较
• 北美：2023-2028 年市场规模与预测
• 欧洲：2023-2028 年市场规模与预测
• 亚洲：2023-2028年市场规模与预测
• 世界其他地区：2023-2028 年市场规模与预测
• 美国：2023-2028 年市场规模与预测
• 德国：2023-2028 年市场规模与预测
• 中国：2023-2028年市场规模及预测
• 法国：2023-2028年市场规模与预测
• 英国：2023-2028 年市场规模与预测
• 市场机会：依地区形势

第 10 章 驱动因素、挑战与趋势

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场趋势

第十一章 供应商形势

• 概述
• 供应商形势
• 混乱的情况
• 产业风险

第十二章供应商分析

• 交易厂商
• 供应商市场定位
• Abbott Laboratories
• B.Braun SE
• Becton Dickinson and Co.
• Bionime Corp.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• iHealth Labs Inc.
• Insulet Corp.
• LifeScan IP Holdings LLC
• Medtronic Plc
• Nemaura Medical Inc.
• Nipro Corp.
• Nova Biomedical Corp.
• Novo Nordisk AS
• PHC Holdings Corp.

第十三章附录

Abstract

The diabetes management devices market is forecasted to grow by USD 13.98 bn during 2023-2028, accelerating at a CAGR of 7.68% during the forecast period. The report on the diabetes management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes, growing demand for advanced insulin delivery devices, and new product launches.

Technavio's diabetes management devices market is segmented as below:

By Product

• Blood glucose monitoring devices
• Insulin delivery systems

By Distribution Channel

• Offline
• Online

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing focus on artificial pancreas as one of the prime reasons driving the diabetes management devices market growth during the next few years. Also, increasing focus on home care settings and technological advancements in healthcare sector will lead to sizable demand in the market.

The report on the diabetes management devices market covers the following areas:

• Diabetes management devices market sizing
• Diabetes management devices market forecast
• Diabetes management devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diabetes management devices market vendors that include Abbott Laboratories, ACON Laboratories Inc., B.Braun SE, Becton Dickinson and Co., Bionime Corp., Dexcom Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., iHealth Labs Inc., Insulet Corp., LifeScan IP Holdings LLC, Medtronic Plc, Nemaura Medical Inc., Nipro Corp., Nova Biomedical Corp., Novo Nordisk AS, PHC Holdings Corp., Prodigy Diabetes Care LL, Tandem Diabetes Care Inc., and WellDoc Inc.. Also, the diabetes management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global diabetes management devices market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global diabetes management devices market 2018 - 2022 ($ billion)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• 4.3 Distribution Channel Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Blood glucose monitoring devices - Market size and forecast 2023-2028
• Exhibit 34: Chart on Blood glucose monitoring devices - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Blood glucose monitoring devices - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Blood glucose monitoring devices - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Blood glucose monitoring devices - Year-over-year growth 2023-2028 (%)
• 6.4 Insulin delivery systems - Market size and forecast 2023-2028
• Exhibit 38: Chart on Insulin delivery systems - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Insulin delivery systems - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Insulin delivery systems - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Insulin delivery systems - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Product
• Exhibit 42: Market opportunity by Product ($ billion)
• Exhibit 43: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 46: Chart on Comparison by Distribution Channel
• Exhibit 47: Data Table on Comparison by Distribution Channel
• 7.3 Offline - Market size and forecast 2023-2028
• Exhibit 48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
• Exhibit 49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
• Exhibit 50: Chart on Offline - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
• 7.4 Online - Market size and forecast 2023-2028
• Exhibit 52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Online - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Online - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Distribution Channel
• Exhibit 56: Market opportunity by Distribution Channel ($ billion)
• Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
• Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 107: Abbott Laboratories - Overview
• Exhibit 108: Abbott Laboratories - Business segments
• Exhibit 109: Abbott Laboratories - Key news
• Exhibit 110: Abbott Laboratories - Key offerings
• Exhibit 111: Abbott Laboratories - Segment focus
• 12.4 B.Braun SE
• Exhibit 112: B.Braun SE - Overview
• Exhibit 113: B.Braun SE - Business segments
• Exhibit 114: B.Braun SE - Key news
• Exhibit 115: B.Braun SE - Key offerings
• Exhibit 116: B.Braun SE - Segment focus
• 12.5 Becton Dickinson and Co.
• Exhibit 117: Becton Dickinson and Co. - Overview
• Exhibit 118: Becton Dickinson and Co. - Business segments
• Exhibit 119: Becton Dickinson and Co. - Key news
• Exhibit 120: Becton Dickinson and Co. - Key offerings
• Exhibit 121: Becton Dickinson and Co. - Segment focus
• 12.6 Bionime Corp.
• Exhibit 122: Bionime Corp. - Overview
• Exhibit 123: Bionime Corp. - Product / Service
• Exhibit 124: Bionime Corp. - Key offerings
• 12.7 Eli Lilly and Co.
• Exhibit 125: Eli Lilly and Co. - Overview
• Exhibit 126: Eli Lilly and Co. - Product / Service
• Exhibit 127: Eli Lilly and Co. - Key news
• Exhibit 128: Eli Lilly and Co. - Key offerings
• 12.8 F. Hoffmann La Roche Ltd.
• Exhibit 129: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 130: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 131: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 132: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 133: F. Hoffmann La Roche Ltd. - Segment focus
• 12.9 iHealth Labs Inc.
• Exhibit 134: iHealth Labs Inc. - Overview
• Exhibit 135: iHealth Labs Inc. - Product / Service
• Exhibit 136: iHealth Labs Inc. - Key offerings
• 12.10 Insulet Corp.
• Exhibit 137: Insulet Corp. - Overview
• Exhibit 138: Insulet Corp. - Product / Service
• Exhibit 139: Insulet Corp. - Key news
• Exhibit 140: Insulet Corp. - Key offerings
• 12.11 LifeScan IP Holdings LLC
• Exhibit 141: LifeScan IP Holdings LLC - Overview
• Exhibit 142: LifeScan IP Holdings LLC - Product / Service
• Exhibit 143: LifeScan IP Holdings LLC - Key offerings
• 12.12 Medtronic Plc
• Exhibit 144: Medtronic Plc - Overview
• Exhibit 145: Medtronic Plc - Business segments
• Exhibit 146: Medtronic Plc - Key news
• Exhibit 147: Medtronic Plc - Key offerings
• Exhibit 148: Medtronic Plc - Segment focus
• 12.13 Nemaura Medical Inc.
• Exhibit 149: Nemaura Medical Inc. - Overview
• Exhibit 150: Nemaura Medical Inc. - Product / Service
• Exhibit 151: Nemaura Medical Inc. - Key offerings
• 12.14 Nipro Corp.
• Exhibit 152: Nipro Corp. - Overview
• Exhibit 153: Nipro Corp. - Business segments
• Exhibit 154: Nipro Corp. - Key offerings
• Exhibit 155: Nipro Corp. - Segment focus
• 12.15 Nova Biomedical Corp.
• Exhibit 156: Nova Biomedical Corp. - Overview
• Exhibit 157: Nova Biomedical Corp. - Product / Service
• Exhibit 158: Nova Biomedical Corp. - Key offerings
• 12.16 Novo Nordisk AS
• Exhibit 159: Novo Nordisk AS - Overview
• Exhibit 160: Novo Nordisk AS - Business segments
• Exhibit 161: Novo Nordisk AS - Key offerings
• Exhibit 162: Novo Nordisk AS - Segment focus
• 12.17 PHC Holdings Corp.
• Exhibit 163: PHC Holdings Corp. - Overview
• Exhibit 164: PHC Holdings Corp. - Business segments
• Exhibit 165: PHC Holdings Corp. - Key offerings
• Exhibit 166: PHC Holdings Corp. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 167: Inclusions checklist
• Exhibit 168: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 169: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 170: Research methodology
• Exhibit 171: Validation techniques employed for market sizing
• Exhibit 172: Information sources
• 13.5 List of abbreviations
• Exhibit 173: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global diabetes management devices market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Product - Market share 2023-2028 (%)
• Exhibits31: Data Table on Product - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on Blood glucose monitoring devices - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Blood glucose monitoring devices - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Blood glucose monitoring devices - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Blood glucose monitoring devices - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Insulin delivery systems - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Insulin delivery systems - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Insulin delivery systems - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Insulin delivery systems - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Product ($ billion)
• Exhibits43: Data Table on Market opportunity by Product ($ billion)
• Exhibits44: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibits45: Data Table on Distribution Channel - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Distribution Channel
• Exhibits47: Data Table on Comparison by Distribution Channel
• Exhibits48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
• Exhibits49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
• Exhibits50: Chart on Offline - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Online - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Online - Year-over-year growth 2023-2028 (%)
• Exhibits56: Market opportunity by Distribution Channel ($ billion)
• Exhibits57: Data Table on Market opportunity by Distribution Channel ($ billion)
• Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits61: Chart on Geographic comparison
• Exhibits62: Data Table on Geographic comparison
• Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits99: Market opportunity By Geographical Landscape ($ billion)
• Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits101: Impact of drivers and challenges in 2023 and 2028
• Exhibits102: Overview on Criticality of inputs and Factors of differentiation
• Exhibits103: Overview on factors of disruption
• Exhibits104: Impact of key risks on business
• Exhibits105: Vendors covered
• Exhibits106: Matrix on vendor position and classification
• Exhibits107: Abbott Laboratories - Overview
• Exhibits108: Abbott Laboratories - Business segments
• Exhibits109: Abbott Laboratories - Key news
• Exhibits110: Abbott Laboratories - Key offerings
• Exhibits111: Abbott Laboratories - Segment focus
• Exhibits112: B.Braun SE - Overview
• Exhibits113: B.Braun SE - Business segments
• Exhibits114: B.Braun SE - Key news
• Exhibits115: B.Braun SE - Key offerings
• Exhibits116: B.Braun SE - Segment focus
• Exhibits117: Becton Dickinson and Co. - Overview
• Exhibits118: Becton Dickinson and Co. - Business segments
• Exhibits119: Becton Dickinson and Co. - Key news
• Exhibits120: Becton Dickinson and Co. - Key offerings
• Exhibits121: Becton Dickinson and Co. - Segment focus
• Exhibits122: Bionime Corp. - Overview
• Exhibits123: Bionime Corp. - Product / Service
• Exhibits124: Bionime Corp. - Key offerings
• Exhibits125: Eli Lilly and Co. - Overview
• Exhibits126: Eli Lilly and Co. - Product / Service
• Exhibits127: Eli Lilly and Co. - Key news
• Exhibits128: Eli Lilly and Co. - Key offerings
• Exhibits129: F. Hoffmann La Roche Ltd. - Overview
• Exhibits130: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits131: F. Hoffmann La Roche Ltd. - Key news
• Exhibits132: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits133: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits134: iHealth Labs Inc. - Overview
• Exhibits135: iHealth Labs Inc. - Product / Service
• Exhibits136: iHealth Labs Inc. - Key offerings
• Exhibits137: Insulet Corp. - Overview
• Exhibits138: Insulet Corp. - Product / Service
• Exhibits139: Insulet Corp. - Key news
• Exhibits140: Insulet Corp. - Key offerings
• Exhibits141: LifeScan IP Holdings LLC - Overview
• Exhibits142: LifeScan IP Holdings LLC - Product / Service
• Exhibits143: LifeScan IP Holdings LLC - Key offerings
• Exhibits144: Medtronic Plc - Overview
• Exhibits145: Medtronic Plc - Business segments
• Exhibits146: Medtronic Plc - Key news
• Exhibits147: Medtronic Plc - Key offerings
• Exhibits148: Medtronic Plc - Segment focus
• Exhibits149: Nemaura Medical Inc. - Overview
• Exhibits150: Nemaura Medical Inc. - Product / Service
• Exhibits151: Nemaura Medical Inc. - Key offerings
• Exhibits152: Nipro Corp. - Overview
• Exhibits153: Nipro Corp. - Business segments
• Exhibits154: Nipro Corp. - Key offerings
• Exhibits155: Nipro Corp. - Segment focus
• Exhibits156: Nova Biomedical Corp. - Overview
• Exhibits157: Nova Biomedical Corp. - Product / Service
• Exhibits158: Nova Biomedical Corp. - Key offerings
• Exhibits159: Novo Nordisk AS - Overview
• Exhibits160: Novo Nordisk AS - Business segments
• Exhibits161: Novo Nordisk AS - Key offerings
• Exhibits162: Novo Nordisk AS - Segment focus
• Exhibits163: PHC Holdings Corp. - Overview
• Exhibits164: PHC Holdings Corp. - Business segments
• Exhibits165: PHC Holdings Corp. - Key offerings
• Exhibits166: PHC Holdings Corp. - Segment focus
• Exhibits167: Inclusions checklist
• Exhibits168: Exclusions checklist
• Exhibits169: Currency conversion rates for US$
• Exhibits170: Research methodology
• Exhibits171: Validation techniques employed for market sizing
• Exhibits172: Information sources
• Exhibits173: List of abbreviations